Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial

Erstveröffentlichung
2020Authors
Herling, Carmen D.
Cymbalista, Florence
Gross-Ophoff-Mueller, Carolin
Bahlo, Jasmin
Robrecht, Sandra
Wissenschaftlicher Artikel
Published in
Leukemia. - : Nature Publishing Group, 2020. - ISSN 0887-6924. - eISSN 1476-5551
Link to publication
https://dx.doi.org/10.1038/s41375-020-0747-7Institutions
UKU. Klinik für Innere Medizin IIIDFG Project THU
SFB 1074 / Experimentelle Modelle und klinische Translation bei Leukämien / DFG / 217328187
Subject headings
[Free subject headings]: INITIAL THERAPY | OPEN-LABEL | FLUDARABINE | RITUXIMAB | CYCLOPHOSPHAMIDE | SURVIVAL | PROGRESSION | CHEMOIMMUNOTHERAPY | QUANTIFICATION | GUIDELINES[DDC subject group]: DDC 610 / Medicine & health